Clinical Trial Update: Metoprolol in Patients With HFrEF and COPD [Phase 4]

View source ↗

Summary

A Phase 4 trial of metoprolol in patients with heart failure with reduced ejection fraction and COPD is planned, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• METOPROLOL (METOPROLOL TARTRATE)

Snippet

Sponsor: Xiangya Hospital of Central South University | Conditions: Heart Failure With Reduced Ejection Fraction (HFrEF), COPD (Chronic Obstructive Pulmonary Disease) | Phase 4 | Status: NOT_YET_RECRUITING